EU-wide tender
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Denosumab, ATC M05BX04 for the period 01.07.2025 - 30.06.2026 (plus extension option 1x 12 months)
Original title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Denosumab, ATC M05BX04 für die Zeit 01.07.2025 - 30.06.2026 (zzgl. Verlängerungsoption 1x 12 Monate)
“Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Denosumab, ATC M05BX04 for the period 01.07.2025 - 30.06.2026 (plus extension option 1x 12 months)” is a eu-wide public tender. Offers are due by Wednesday, 5 May 2027, in 185 days. Procedure: Open procedure, published EU-wide (above the EU thresholds).
- Deadline
- 5 May 2027, 185 days left, 12:00
- Published
- 20 May 2025
- Procedure
- Open procedure
- Notice
- EU-wide (TED)
- Type of contract
- Supplies
- Estimated value
- not published
- Place of performance
- not stated
- Source, last checked
- TED, 1 November 2026
Contracting authority and documents
Contracting authority only with access
Original notice (German)Tender documents on the procurement platformIn short
Discount agreement for Denosumab medications for DAK-Gesundheit
- Non-exclusive discount agreement for the active substance Denosumab
- Term from 1 July 2025 to 30 June 2026 with extension option
- Accession for pharmaceutical companies possible at any time under the same conditions
- Submission of offers exclusively by email to [email protected]
- Documents must be submitted by the 5th of the preceding month for accession in the following month
Summary made from the German notice and checked against it; the German original is authoritative.
Worth knowing before you bid
The notice links the tender documents directly. The contract runs for 12 months.
Deadlines and dates
| Published | Tuesday, 20 May 2025 |
|---|---|
| Deadline | Wednesday, 5 May 2027, 12:00 |
| Tender validity ends (calculated) | Friday, 4 June 2027 |
Conditions stated in the notice
| Duration | 12 months |
|---|---|
| Framework agreement | no |
| Tender validity | 1 month after the deadline |
| Suitable for SMEs | not stated |
| Security deposit | not required |
| Legal basis | GWB and VgV (German law implementing the EU directives) |
Service by CPV code
- 33600000 Pharmaceutical products
Questions and answers
How much time is left to bid?
Until Wednesday, 5 May 2027, 185 days left. The exact time and how to submit are in the original notice, which is authoritative.
In which language are the documents and the offer?
Usually German. The notice states the accepted languages; translations of supporting documents may be requested.
Can a company from another EU country bid?
Yes. This tender is published EU-wide, and above the EU thresholds the EU directives guarantee companies from every member state equal treatment. You submit on the platform named in the notice after registering there.
Which rules apply?
German procurement law implementing the EU directives (GWB and VgV; for works VOB/A EU).
Sources
Notice: TED, Amtsblatt der Europäischen Union, retrieved 1 November 2026. All information without guarantee; the original notice is authoritative.